Aridis Pharmaceuticals In... (ARDS)
OTC: ARDS
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 01, 2025, 9:51 AM
Aridis Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 35K | 19K | 1.32M | 4.88M | 1.89M | 6.32M | 12.47M | 19.99M | 18.22M | 3.59M | 10.47M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 827K | 827K | 906K | 905K | 961K | 1.01M | 1.02M | 1.03M | 1.03M | 1.06M | 1.06M |
Receivables | 517K | 300K | 100K | 1.24M | 248K | 1.59M | 395K | 237K | 1.22M | 137K | 494K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -237K | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | 1.99M | 2.17M | 2.73M | 3.12M | 4.49M | 3.35M | 1.96M | 1.98M | 1.98M |
Total Current Assets | 4.11M | 3.88M | 6.57M | 11.63M | 8.63M | 12.91M | 19.77M | 26.8M | 23.58M | 8.94M | 15.1M |
Property-Plant & Equipment | 1.58M | 1.76M | 1.95M | 2.15M | 2.51M | 2.74M | 3.01M | 1.36M | 1.45M | 1.37M | 1.38M |
Goodwill & Intangibles | 13K | 14K | 15K | 17K | 18K | 19K | 21K | 22K | 23K | 24K | 26K |
Total Long-Term Assets | 2.42M | 2.6M | 2.87M | 3.07M | 3.48M | 3.77M | 4.05M | 2.41M | 2.5M | 2.45M | 2.47M |
Total Assets | 6.53M | 6.48M | 9.43M | 14.7M | 12.12M | 16.69M | 23.82M | 26.8M | 26.09M | 11.39M | 17.57M |
Account Payables | 5.41M | 6.24M | 4.12M | 2.31M | 4.23M | 2.56M | 3.03M | 5.24M | 2.64M | 2.46M | 3.21M |
Deferred Revenue | 380K | 380K | 19.09M | 20.17M | 20.39M | 20.73M | 20.96M | 20.84M | 19.58M | 19.27M | 19.31M |
Short-Term Debt | 3.41M | 4.73M | 2.25M | 4.3M | 8.63M | n/a | 139K | 696K | n/a | n/a | 605K |
Other Current Liabilities | 15K | 23K | 15K | 15K | 15K | 15K | 15K | 110K | 100K | 92K | 91K |
Total Current Liabilities | 17.48M | 20.39M | 35.43M | 36.9M | 42.28M | 31.34M | 31.01M | 33.35M | 28.89M | 23.68M | 24.8M |
Long-Term Debt | n/a | n/a | n/a | n/a | 3.5M | 1.56M | 1.71M | 5.28M | n/a | n/a | 110K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 9.36M | 8.94M | 363K | 382K | 398K | 421K |
Total Long-Term Liabilities | 854K | 1M | 1.89M | 2.03M | 5.67M | 13.28M | 13.21M | 6.56M | 1.35M | 1.19M | 1.33M |
Total Liabilities | 18.34M | 21.4M | 37.32M | 38.93M | 47.94M | 44.62M | 44.23M | 40.91M | 30.24M | 24.87M | 26.12M |
Total Debt | 4.84M | 6.29M | 3.95M | 6.13M | 14.08M | 13M | 12.99M | 5.98M | n/a | n/a | 715K |
Common Stock | 5K | 4K | 4K | 3K | 2K | 2K | 2K | 2K | 1K | 1K | 1K |
Retained Earnings | -190.42M | -190.34M | -202.48M | -195.67M | -189.28M | -181.04M | -173.06M | -165.29M | -156.49M | -135.48M | -129.99M |
Comprehensive Income | 7.79M | 6.53M | 5.91M | 5.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -11.8M | -14.91M | -27.88M | -24.23M | -35.82M | -27.93M | -20.41M | -14.11M | -4.16M | -13.49M | -8.55M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |